UBS Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Buy |
639,462
+47,052
| +8% | +$171K | ﹤0.01% | 3696 |
|
|
2025
Q1 | $1.14M | Buy |
592,410
+241,319
| +69% | +$463K | ﹤0.01% | 4095 |
|
|
2024
Q4 | $667K | Buy |
351,091
+197,429
| +128% | +$375K | ﹤0.01% | 4515 |
|
|
2024
Q3 | $203K | Buy |
153,662
+10,834
| +8% | +$14.3K | ﹤0.01% | 4691 |
|
|
2024
Q2 | $146K | Buy |
142,828
+43,490
| +44% | +$44.4K | ﹤0.01% | 4768 |
|
|
2024
Q1 | $182K | Sell |
99,338
-57,692
| -37% | -$106K | ﹤0.01% | 4774 |
|
|
2023
Q4 | $195K | Buy |
157,030
+88,302
| +128% | +$109K | ﹤0.01% | 4616 |
|
|
2023
Q3 | $78.3K | Sell |
68,728
-2,760
| -4% | -$3.15K | ﹤0.01% | 4874 |
|
|
2023
Q2 | $65.4K | Sell |
71,488
-16,487
| -19% | -$15.1K | ﹤0.01% | 5258 |
|
|
2023
Q1 | $49.3K | Buy |
87,975
+29,220
| +50% | +$16.4K | ﹤0.01% | 5387 |
|
|
2022
Q4 | $34.1K | Sell |
58,755
-73,206
| -55% | -$42.5K | ﹤0.01% | 5951 |
|
|
2022
Q3 | $41K | Buy |
131,961
+1,309
| +1% | +$407 | ﹤0.01% | 5459 |
|
|
2022
Q2 | $46K | Sell |
130,652
-638,786
| -83% | -$225K | ﹤0.01% | 4964 |
|
|
2022
Q1 | $553K | Buy |
769,438
+286,788
| +59% | +$206K | ﹤0.01% | 3686 |
|
|
2021
Q4 | $1.09M | Sell |
482,650
-46,195
| -9% | -$104K | ﹤0.01% | 3377 |
|
|
2021
Q3 | $1.52M | Buy |
528,845
+390,489
| +282% | +$1.12M | ﹤0.01% | 2946 |
|
|
2021
Q2 | $524K | Sell |
138,356
-189,925
| -58% | -$719K | ﹤0.01% | 3717 |
|
|
2021
Q1 | $1.11M | Buy |
328,281
+192,034
| +141% | +$650K | ﹤0.01% | 3265 |
|
|
2020
Q4 | $381K | Sell |
136,247
-33,816
| -20% | -$94.6K | ﹤0.01% | 3876 |
|
|
2020
Q3 | $427K | Buy |
170,063
+39,738
| +30% | +$99.8K | ﹤0.01% | 3537 |
|
|
2020
Q2 | $1.77M | Sell |
130,325
-27,162
| -17% | -$369K | ﹤0.01% | 2373 |
|
|
2020
Q1 | $1.19M | Sell |
157,487
-65,089
| -29% | -$493K | ﹤0.01% | 2533 |
|
|
2019
Q4 | $1.41M | Sell |
222,576
-94,013
| -30% | -$594K | ﹤0.01% | 3057 |
|
|
2019
Q3 | $1.24M | Buy |
316,589
+61,680
| +24% | +$242K | ﹤0.01% | 3026 |
|
|
2019
Q2 | $1.23M | Buy |
254,909
+107,075
| +72% | +$518K | ﹤0.01% | 2884 |
|
|
2019
Q1 | $1.21M | Sell |
147,834
-36,319
| -20% | -$298K | ﹤0.01% | 2781 |
|
|
2018
Q4 | $1.02M | Buy |
184,153
+24,356
| +15% | +$135K | ﹤0.01% | 2977 |
|
|
2018
Q3 | $1.41M | Buy |
159,797
+27,677
| +21% | +$244K | ﹤0.01% | 2867 |
|
|
2018
Q2 | $1.32M | Sell |
132,120
-60,229
| -31% | -$601K | ﹤0.01% | 2858 |
|
|
2018
Q1 | $1.83M | Buy |
192,349
+76,480
| +66% | +$729K | ﹤0.01% | 2615 |
|
|
2017
Q4 | $1.72M | Buy |
115,869
+39,491
| +52% | +$587K | ﹤0.01% | 2634 |
|
|
2017
Q3 | $1.5M | Sell |
76,378
-34,894
| -31% | -$686K | ﹤0.01% | 2697 |
|
|
2017
Q2 | $1.6M | Sell |
111,272
-40,374
| -27% | -$580K | ﹤0.01% | 2563 |
|
|
2017
Q1 | $1.4M | Buy |
151,646
+66,948
| +79% | +$616K | ﹤0.01% | 2603 |
|
|
2016
Q4 | $882K | Sell |
84,698
-14,489
| -15% | -$151K | ﹤0.01% | 2903 |
|
|
2016
Q3 | $898K | Sell |
99,187
-4,280
| -4% | -$38.7K | ﹤0.01% | 2798 |
|
|
2016
Q2 | $774K | Buy |
103,467
+28,059
| +37% | +$210K | ﹤0.01% | 2879 |
|
|
2016
Q1 | $679K | Sell |
75,408
-15,623
| -17% | -$141K | ﹤0.01% | 2916 |
|
|
2015
Q4 | $1.18M | Buy |
91,031
+57,982
| +175% | +$749K | ﹤0.01% | 2585 |
|
|
2015
Q3 | $319K | Sell |
33,049
-33,244
| -50% | -$321K | ﹤0.01% | 3393 |
|
|
2015
Q2 | $682K | Buy |
66,293
+54,417
| +458% | +$560K | ﹤0.01% | 3051 |
|
|
2015
Q1 | $132K | Buy |
11,876
+395
| +3% | +$4.39K | ﹤0.01% | 4031 |
|
|
2014
Q4 | $134K | Buy |
+11,481
| New | +$134K | ﹤0.01% | 4033 |
|